Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Cytosorbents (CTSO) over the last 15 years, with Q3 2025 value amounting to $3.6 million.

  • Cytosorbents' Other Non-Current Assets fell 4375.35% to $3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year decrease of 4375.35%. This contributed to the annual value of $3.8 million for FY2024, which is 473.91% down from last year.
  • Latest data reveals that Cytosorbents reported Other Non-Current Assets of $3.6 million as of Q3 2025, which was down 4375.35% from $3.8 million recorded in Q2 2025.
  • In the past 5 years, Cytosorbents' Other Non-Current Assets registered a high of $6.5 million during Q2 2024, and its lowest value of $3.6 million during Q3 2025.
  • For the 5-year period, Cytosorbents' Other Non-Current Assets averaged around $4.5 million, with its median value being $4.4 million (2023).
  • Per our database at Business Quant, Cytosorbents' Other Non-Current Assets surged by 5628.77% in 2024 and then crashed by 4375.35% in 2025.
  • Over the past 5 years, Cytosorbents' Other Non-Current Assets (Quarter) stood at $5.0 million in 2021, then decreased by 10.51% to $4.4 million in 2022, then fell by 10.79% to $4.0 million in 2023, then decreased by 4.74% to $3.8 million in 2024, then fell by 3.29% to $3.6 million in 2025.
  • Its Other Non-Current Assets stands at $3.6 million for Q3 2025, versus $3.8 million for Q2 2025 and $3.8 million for Q1 2025.